1 |
Zamboni G, Pea M, Martignoni G, et al.Clear cell "sugar" tumor of the pancreas.A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells [J].Am J Surg Pathol.1996 Jun;20(6):722-730.
|
2 |
Lin Z, Ding Z, Jiang H.Recurrent epithelioid angiomyolipoma of the adrenal gland: a case report and literature review [J].AME Case Rep,2024, 8: 57.
|
3 |
Folpe AL, Mentzel T, Lehr HA, et al.Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature [J].Am J Surg Pathol,2005, 29(12): 1558-1575.
|
4 |
宣兰兰, 魏建国, 刘红刚.血管周上皮样细胞肿瘤的病理诊断及新进展 [J].中华病理学杂志, 2021, 50(3): 282-282.
|
5 |
Dhaliwal K, Marslender S.Malignant retroperitoneal PEComa: A case report with emphasis on radiological findings [J].Radiol Case Rep,2023, 18(3): 1358-1363.
|
6 |
Czarnecka AM, Skoczylas J, Bartnik E, et al.Management strategies for adults with locally advanced, unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa): challenges and solutions[J].Cancer Manag Res, 2023, 15: 615-623.
|
7 |
Gao X, Tang H, Wang J, et al.Specific imaging features indicate the clinical features of patients with hepatic perivascular epithelioid cell tumor by comparative analysis of CT and ultrasound imaging [J].Front Oncol, 2022, 12: 908189.
|
8 |
Yim H, Tang YL, Tandon AA.Multifocal retroperitoneal and pelvic PEComas mimicking liposarcoma: A case report and review of literature [J].Radiol Case Rep, 2021, 16(9): 2624-2629.
|
9 |
马得贝, 叶兆祥, 刘颖, 等.腹膜后去分化脂肪肉瘤的CT 和MRI表现 [J].中国肿瘤临床, 2023, 50(24): 1254-1258.
|
10 |
Yuan X, Liu Y, Wang X, et al.Clinicopathological analysis of retroperitoneal solitary fibrous tumours: a study of 31 病例s.Histol Histopathol.2022 Jan;37(1):43-50.
|
11 |
刘磊, 唐世英, 张启鸣, 等.腹膜后血管源性平滑肌肉瘤诊疗策略[J].重庆医科大学学报, 2023, 48(8): 953-957.
|
12 |
高峻, 李玉标, 吴航, 等.腹膜后间隙孤立肿块性淋巴瘤的CT 表现及其解剖学基础 [J].中国临床解剖学杂志, 2023, 41(6): 662-666, 674.
|
13 |
Yan J, Zhou D, Wang Y, et al.A retrospective clinical analysis of 11 病例s of PEComa from different sites [J].World J Surg Oncol, 2024, 22(1): 116.
|
14 |
Purwar R, Soni K, Shukla M, et al.TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review [J].World J Surg Oncol, 2022, 20(1): 62.
|
15 |
王军, 刘鲲鹏, 姚兰, 等.腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析 [J/OL].中华临床医师杂志(电子版), 2023,17(8): 844-849.
|
16 |
Bourgmayer A, Nannini S, Bonjean P, et al.Natural history and treatment strategies of advanced PEComas: a systematic review [J].Cancers (Basel), 2021, 13(20): 5227.
|
17 |
Wagner AJ, Ravi V, Riedel RF, et al.Phase II trial of nab-sirolimus in patients with Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): long-term efficacy and safety update [J].J Clin Oncol, 2024, 42(13): 1472-1476.
|
18 |
Liapi A, Mathevet P, Herrera FG, et al.VEGFR inhibitors for uterine metastatic perivascular epithelioid tumors (PEComa) resistant to mTOR inhibitors.A case report and review of literature [J].Front Oncol, 2021, 11: 641376.
|